The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.
With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...
Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...
Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...
For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...
The unassuming yet popular white button mushroom has cancer-fighting abilities, according to the results of a human clinical ...
China: A recent randomized clinical trial published in JAMA investigated the effectiveness of Tenofovir (TDF) in preventing ...
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a ...
12h
Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers ...
A new treatment for an aggressive blood cancer developed in Australia is proving a lifesaver for patients who had run out of ...
GATC West Virginia is making progress in medical innovation at its headquarters in the WVU Innovation Corp. Their lab is up ...
A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback